Found: 17
Select item for more details and to access through your institution.
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry.
- Published in:
- Journal of Central Nervous System Disease, 2024, p. 1, doi. 10.1177/11795735241262743
- By:
- Publication type:
- Article
Quantiferon Monitor Testing Sheds Light on Immune System Disparities between Multiple Sclerosis Patients and Healthy Individuals.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2179, doi. 10.3390/ijms25042179
- By:
- Publication type:
- Article
Modulátory sfingosin-1-fosfátového receptoru v léčbě časné fáze roztroušené sklerózy.
- Published in:
- Neurologie Pro Praxi, 2023, v. 24, n. 5, p. 360, doi. 10.36290/neu.2023.064
- By:
- Publication type:
- Article
Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis.
- Published in:
- European Neurology, 2023, v. 86, n. 5, p. 334, doi. 10.1159/000532022
- By:
- Publication type:
- Article
Zlepšení kognitivních funkcí a zaměstnanosti u pacientů s relabující formou roztroušené sklerózy léčených okrelizumabem.
- Published in:
- Neurologie Pro Praxi, 2023, v. 24, n. 4, p. 264, doi. 10.36290/neu.2023.047
- By:
- Publication type:
- Article
Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor.
- Published in:
- Journal of Immunology Research, 2023, p. 1, doi. 10.1155/2023/4653627
- By:
- Publication type:
- Article
Komentář: Dlouhodobá účinnost a bezpečnost siponimodu v léčbě sekundárně progresivní roztroušené sklerózy.
- Published in:
- Remedia, 2022, v. 32, n. 5, p. 446
- By:
- Publication type:
- Article
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.851426
- By:
- Publication type:
- Article
Ofatumumab a siponimod rozšiřují možnosti léčby relabující remitentní a sekundárně progresivní roztroušené sklerózy.
- Published in:
- Neurologie Pro Praxi, 2022, v. 23, p. 4
- By:
- Publication type:
- Article
Natalizumab v léčbě roztroušené sklerózy – dlouholeté zkušenosti a nová subkutánní forma.
- Published in:
- Neurologie Pro Praxi, 2022, v. 23, p. 10
- By:
- Publication type:
- Article
Kratší doba podání ocrelizumabu při léčbě roztroušené sklerózy.
- Published in:
- Neurologie Pro Praxi, 2021, v. 22, n. 4, p. 300
- By:
- Publication type:
- Article
Siponimod -- první lék u sekundárně progresivní roztroušené sklerózy v klinické praxi.
- Published in:
- Neurologie Pro Praxi, 2021, v. 22, n. 4, p. 320, doi. 10.36290/neu.2021.047
- By:
- Publication type:
- Article
Léčba roztroušené sklerózy perorálním kladribinem.
- Published in:
- Neurologie Pro Praxi, 2021, v. 22, n. 3, p. 226
- By:
- Publication type:
- Article
Časná diagnostika a léčba roztroušené sklerózy.
- Published in:
- Neurologie Pro Praxi, 2021, v. 22, n. 2, p. 128
- By:
- Publication type:
- Article
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.593527
- By:
- Publication type:
- Article
Dlouhodobá bezpečnost ocrelizumabu při léčbě roztroušené sklerózy.
- Published in:
- Neurologie Pro Praxi, 2020, v. 21, n. 4, p. 291
- By:
- Publication type:
- Article
Dlouhodobá bezpečnost ocrelizumabu při léčbě roztroušené sklerózy.
- Published in:
- Neurologie Pro Praxi, 2020, p. 291
- By:
- Publication type:
- Article